Objectives

1)Development of a pen-side diagnostic test for Theileriaparva using the CRISPR-Cas technology to support farm-level rapid diagnosis & response to ECF in the field.

2)Development of a multiplex CRISPR-Cas diagnostic assay to support vaccine and epidemiological research.